116 related articles for article (PubMed ID: 20706284)
41. What constitutes "improved prognosis"?
Canellos GP
J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
[No Abstract] [Full Text] [Related]
42. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ
J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935
[TBL] [Abstract][Full Text] [Related]
43. Treatment of primary intraocular lymphoma with rituximab, high dose methotrexate, procarbazine, and vincristine chemotherapy, reduced whole-brain radiotherapy, and local ocular therapy.
Taoka K; Yamamoto G; Kaburaki T; Takahashi T; Araie M; Kurokawa M
Br J Haematol; 2012 Apr; 157(2):252-4. PubMed ID: 22085111
[No Abstract] [Full Text] [Related]
44. Smudge in my vision.
Nwanyanwu KH; Lim JI
JAMA Ophthalmol; 2013 Dec; 131(12):1637-8. PubMed ID: 24337560
[No Abstract] [Full Text] [Related]
45. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
Natkunam Y; Farinha P; Hsi ED; Hans CP; Tibshirani R; Sehn LH; Connors JM; Gratzinger D; Rosado M; Zhao S; Pohlman B; Wongchaowart N; Bast M; Avigdor A; Schiby G; Nagler A; Byrne GE; Levy R; Gascoyne RD; Lossos IS
J Clin Oncol; 2008 Jan; 26(3):447-54. PubMed ID: 18086797
[TBL] [Abstract][Full Text] [Related]
46. Richter's transformation of chronic lymphocytic leukemia.
Giardino AA; O'Regan K; Jagannathan JP; Elco C; Ramaiya N; Lacasce A
J Clin Oncol; 2011 Apr; 29(10):e274-6. PubMed ID: 21220587
[No Abstract] [Full Text] [Related]
47. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
48. Intravitreal methotrexate for retinoblastoma.
Kivelä T; Eskelin S; Paloheimo M
Ophthalmology; 2011 Aug; 118(8):1689, 1689.e1-6. PubMed ID: 21813093
[No Abstract] [Full Text] [Related]
49. Use of intravitreal rituximab and methotrexate in vitreoretinal lymphoma.
Rahhal-Ortuño M; Udaondo-Mirete P; Fernández-Santodomingo AS; Díaz-Llopis M
Eur J Ophthalmol; 2022 Jan; 32(1):NP199-NP202. PubMed ID: 32985253
[TBL] [Abstract][Full Text] [Related]
50. Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.
Dujmovic D; Aurer I; Radman I; Serventi-Seiwerth R; Dotlic S; Stern-Padovan R; Dubravcic K; Santek F; Labar B
Acta Haematol; 2012; 127(2):115-7. PubMed ID: 22212303
[No Abstract] [Full Text] [Related]
51. Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage.
Matsuyama J; Ichikawa M; Oikawa T; Sato T; Kishida Y; Oda K; Maeda T; Yamada M; Kuromi Y; Matsumoto Y; Ando H; Sakuma J; Saito K
Brain Tumor Pathol; 2014 Jul; 31(3):222-8. PubMed ID: 23999767
[TBL] [Abstract][Full Text] [Related]
52. [Diffue large B-cell lymphoma in a child treated by rituximab complicated with chemotherapy].
Chang J; Wang LJ; Wang LZ; Zhang YT; Zhong XD
Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):387-8. PubMed ID: 22613114
[No Abstract] [Full Text] [Related]
53. Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
Kersten MJ; Kraan W; Doorduijn J; Bromberg J; Lam K; Kluin PM; van der Holt BJ; Spaargaren M; Pals ST
Blood Cancer J; 2014 Dec; 4(12):e266. PubMed ID: 25501023
[No Abstract] [Full Text] [Related]
54. Old versus frail: why it matters in lymphoma.
Ramsdale E; Smith S
Leuk Lymphoma; 2011 Jun; 52(6):938-40. PubMed ID: 21599587
[No Abstract] [Full Text] [Related]
55. Neoplastic lymphomatous submaculopathy.
Testi I; Agarwal A; Gupta V;
Indian J Ophthalmol; 2019 Dec; 67(12):2051-2052. PubMed ID: 31755451
[No Abstract] [Full Text] [Related]
56. Methotrexate-Induced Acute Necrotizing Leukoencephalopathy: Role of Aminophylline?
Muzaffar M; Chai M
Am J Ther; 2017; 24(1):e104-e105. PubMed ID: 27574937
[No Abstract] [Full Text] [Related]
57. CNS prophylaxis in diffuse large B-cell lymphoma.
Mori J; Takahashi Y; Tsubokura M; Matsumura T; Kami M
Lancet; 2012 Apr; 379(9825):1486; author reply 1486-7. PubMed ID: 22521067
[No Abstract] [Full Text] [Related]
58. CNS prophylaxis in diffuse large B-cell lymphoma.
Tanimoto T; Kusumi E; Hosoda K; Tajima F; Oshima Y
Lancet; 2012 Apr; 379(9825):1485-6; author reply 1486-7. PubMed ID: 22521065
[No Abstract] [Full Text] [Related]
59. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma.
de Smet MD; Vancs VS; Kohler D; Solomon D; Chan CC
Br J Ophthalmol; 1999 Apr; 83(4):448-51. PubMed ID: 10434868
[TBL] [Abstract][Full Text] [Related]
60. Anti-CD20 monoclonal antibody therapy and minimal residual disease status of T-cell/histiocyte-rich large B cell non-Hodgkin lymphoma.
Valera ET; Queiroz RG; Brassesco MS; Scrideli CA; Neves F; Tone LG
Pediatr Blood Cancer; 2011 Aug; 57(2):348-9. PubMed ID: 21480472
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
